Fundraising FoxGREAT LAKES BAY VENTURE — Full Portfolio
2 tracked investments · listed companies and verified rows first
MetaVia is a clinical-stage biotechnology company developing therapeutics for cardiometabolic diseases, including DA-1726 for obesity and vanoglipel (DA-1241) for Metabolic Dysfunction-Associated Steatohepatitis (MASH).
BiotechHealthtechCambridge, US
Mina Sooch(Executive Officer)Hyung Heon Kim(Executive Officer, Director)Margaret McShane(Executive Officer)David Lowenschuss(Executive Officer)Marshall Woodworth(Chief Financial Officer)Charles Bisgaier(Executive Officer)
Board seatKenneth Kousky· per SEC Form D · $12.5M raise · filed Mar 2017
Co-investorsExcel Venture Management
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.